Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Physiol ; 581(Pt 3): 1323-32, 2007 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-17430988

RESUMO

In pregnant women with type 1 diabetes, suboptimal glucose control in the first trimester is a strong predictor for giving birth to a large fetus. However, the mechanisms underlying this association are unknown. We hypothesized that transient hyperglycaemia in early pregnancy results in (1) increased placental growth and (2) an up-regulation of placental nutrient transport capacity, which leads to fetal overgrowth at term. In order to test this hypothesis, pregnant rats were given intraperitoneal injections of glucose (2 g kg(-1), resulting in a 50-100% increase in blood glucose level during 90 min) or saline (control) in either early or late gestation using four different protocols: one single injection on gestational day (GD) 10 (n=5), three injections on GD 10 (n=8-9), six injections on GD 10 and 11 (n=9-11) or three injections on GD 19 (n=7-8). Multiple injections were given approximately 4 h apart. Subsequently, animals were studied on GD 21. Three glucose injections in early pregnancy significantly increased placental weight by 10%, whereas fetal weight was found to be increased at term in response to both three (9% increase in fetal weight, P<0.05) and six glucose injections (7%, P=0.05) in early gestation. A single glucose injection on GD 10 or three injections of glucose on GD 19 had no effect on placental or fetal growth. In groups where a change in feto-placental growth was observed, we measured placental system A and glucose transport activity in the awake animals on GD 21 and placental expression of the glucose and amino acid transporters GLUT1, GLUT3, SNAT2 (system A), LAT1 and LAT 2 (system L). Placental system A transport at term was down-regulated by six glucose injections in early pregnancy (by -33%, P<0.05), whereas placental mRNA and protein levels were unchanged. No long-term alterations in maternal metabolic status were detected. In conclusion, we demonstrate that transient hyperglycaemia in early pregnancy is sufficient to increase fetal weight close to term. In contrast, brief hyperglycaemia in late pregnancy did not stimulate fetal growth. Increased fetal growth may be explained by a larger placenta, which would allow for more nutrients to be transferred to the fetus. These data suggest that maternal metabolic control in early pregnancy is an important determinant for feto-placental growth and placental function throughout the remainder of gestation. We speculate that maternal metabolism in early pregnancy represents a key environmental cue to which the placenta responds in order to match fetal growth rate with the available resources of the mother.


Assuntos
Sistemas de Transporte de Aminoácidos Neutros/metabolismo , Diabetes Gestacional/metabolismo , Transtornos da Nutrição Fetal/etiologia , Peso Fetal , Proteínas Facilitadoras de Transporte de Glucose/metabolismo , Hiperglicemia/metabolismo , Troca Materno-Fetal , Placenta/metabolismo , Sistema A de Transporte de Aminoácidos , Sistema y+ de Transporte de Aminoácidos/metabolismo , Sistemas de Transporte de Aminoácidos/metabolismo , Sistemas de Transporte de Aminoácidos Neutros/genética , Animais , Glicemia/metabolismo , Diabetes Gestacional/sangue , Diabetes Gestacional/induzido quimicamente , Diabetes Gestacional/patologia , Modelos Animais de Doenças , Feminino , Transtornos da Nutrição Fetal/sangue , Transtornos da Nutrição Fetal/metabolismo , Transtornos da Nutrição Fetal/patologia , Cadeias Leves da Proteína-1 Reguladora de Fusão/metabolismo , Idade Gestacional , Glucose , Proteínas Facilitadoras de Transporte de Glucose/genética , Transportador de Glucose Tipo 1/metabolismo , Transportador de Glucose Tipo 3/metabolismo , Hiperglicemia/sangue , Hiperglicemia/induzido quimicamente , Hiperglicemia/complicações , Hiperglicemia/patologia , Insulina/sangue , Transportador 1 de Aminoácidos Neutros Grandes/metabolismo , Tamanho do Órgão , Placenta/patologia , Gravidez , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley
2.
Mamm Genome ; 13(6): 302-9, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12115033

RESUMO

The rat provides valuable and sometimes unique models of human complex diseases. To fully exploit the rat models in biomedical research, it is important to have access to detailed knowledge of the rat genome organization as well as its relation to the human genome. Rat Chromosome 10 (RNO10) harbors several important cancer-related genes. Deletions in the proximal part of RNO10 were repeatedly found in a rat model for endometrial cancer. To identify functional and positional candidate genes in the affected region, we used radiation hybrid (RH) mapping and single- and dual-color fluorescence in situ hybridization (FISH) techniques to construct a detailed chromosomal map of the proximal part of RNO10. The regional localization of 14 genes, most of them cancer-related ( Grin2a, Gspt1, Crebbp, Gfer, Tsc2, Tpsb1, Il9r, Il4, Irf1, Csf2, Sparc, Tp53, Thra1, Gh1), and of five microsatellite markers ( D10Mit10, D10Rat42, D10Rat50, D10Rat72, and D10Rat165) was determined on RNO10. For a fifteenth gene, Ppm1b, which had previously been assigned to RNO10, the map position was corrected to RNO6q12-q13.


Assuntos
Mapeamento de Híbridos Radioativos , Animais , Humanos , Hibridização in Situ Fluorescente , Camundongos , Repetições de Microssatélites , Dados de Sequência Molecular , Ratos , Alinhamento de Sequência , Análise de Sequência de DNA , Sintenia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA